Zura Bio Limited's Customers Performance

Name: Zura Bio Limited Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

ZURA

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


ZURA's Source of Revenues		• List of ZURA Customers

for the same period Zura Bio Limited

• List of ZURA Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Zura Bio Limited's Comment on Sales, Marketing and Customers

News about Zura Bio Limited Contracts

“Zura Bio Limited Navigating Financial Waters with Resilience in Q3 2025”

Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates In a recent announcement, Zura Bio Limited (NASDAQ: ZURA) reported its financial results for the third quarter of 2025, revealing critical insights into the company’s performance and strategic direction. With 94.29 million shares outstanding, Zura Bio has established its current stock price at $4.63, indicating a stable position in the competitive biotech market. Financial OverviewThe third quarter results showcased Zura Bio s commitment to innovation and growth despite an evolving economic landscape. The company reported revenues that reflected its ongoing research and development efforts, which are aimed at addressing unme...

Zura Bio Successfully Concludes Warrant Exchange Offer and Consent Solicitation

In a recent announcement, Zura Bio Limited, a clinical-stage immunology company focused on developing innovative dual-pathway antibodies for autoimmune and inflammatory diseases, disclosed the expiration and outcomes of its exchange offer and consent solicitation. These initiatives pertained to the company s outstanding public warrants, which were originally issued during its initial public offering (IPO).The exchange offer was designed to provide warrant holders with the opportunity to exchange existing warrants for a more favorable equity-based security. This move is intended to streamline Zura Bio s capital structure while potentially increasing the company s financial flexibility as it progresses through...

ZURA's Stock Performance relative to it's Customers

ZURA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Zura Bio Limited	682.21	0.00	-101.27	40
SUBTOTAL	0.00	0.00	0.00	-

Sources: Zura Bio Limited’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Zura Bio Limited’s corporate clients.
For your research, we’ve provided 9 tables on Zura Bio Limited corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.